72 related articles for article (PubMed ID: 2652600)
1. Evaluation of monocyte procoagulant activity as a parameter for immunologic monitoring in renal transplantation.
Zappala SM; Khauli RB; Miller-Graziano C; Takayama TK; Stoff JS; Menon M
Transplant Proc; 1989 Feb; 21(1 Pt 2):1844-5. PubMed ID: 2652600
[No Abstract] [Full Text] [Related]
2. Use of monoclonal antibodies to T cells (OKT3) for treatment of acute cellular rejection after renal transplantation.
Birkeland SA; Svendsen V; Rohr N; Hansen BL; Elbirk A; Foged N; Køhler F
Transplant Proc; 1988 Jun; 20(3):451-4. PubMed ID: 3289183
[No Abstract] [Full Text] [Related]
3. BT563 significantly decreases sIL-2R plasma levels despite acute allograft rejection.
Mueller AR; Platz KP; Steinmüller T; Nüssler N; Neumann U; Gerlach H; Stoll C; Bechstein WO; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3103-5. PubMed ID: 8962203
[No Abstract] [Full Text] [Related]
4. Immunologic monitoring of antithymocyte globulin treatment for acute allograft rejection.
Delmonico FL; Nelson PW; Colvin RB; Cosimi AB
Transplant Proc; 1984 Dec; 16(6):1492-3. PubMed ID: 6390852
[No Abstract] [Full Text] [Related]
5. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
[No Abstract] [Full Text] [Related]
6. Pre-operative interleukin 2 and interleukin 2 receptor levels may predict subsequent renal allograft rejection.
Cornaby AJ; Simpson MA; Madras PN; Dempsey RA; Clowes GH; Monaco AP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1861-2. PubMed ID: 2652604
[No Abstract] [Full Text] [Related]
7. Monitoring antithymocyte globulin in renal transplantation.
Clark K
Ann R Coll Surg Engl; 1996 Nov; 78(6):536-40. PubMed ID: 8943640
[No Abstract] [Full Text] [Related]
8. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary?
Renlund DG; O'Connell JB; Bristow MR
J Heart Transplant; 1989; 8(3):191-3. PubMed ID: 2661767
[No Abstract] [Full Text] [Related]
9. Inducible IL-2 on CD8 lymphocytes as a postoperative predictor of rejection in renal allograft recipients.
Langley J; Dickerman R; Vergne-Marini P; Williams J; Jensik S; Kenyon N; Anderson J
Transplant Proc; 1993 Feb; 25(1 Pt 2):939-43. PubMed ID: 8442275
[No Abstract] [Full Text] [Related]
10. The significance of elevated procoagulant activity in the monocytes of renal transplant recipients.
Halloran P; Aprile M; Haddad G; Robinette M
Transplant Proc; 1982 Dec; 14(4):669-72. PubMed ID: 6762724
[No Abstract] [Full Text] [Related]
11. Evolution of chronic antibody mediated-rejection: a case report.
Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
[No Abstract] [Full Text] [Related]
12. Rejection treatment by polyclonal antibodies in kidney transplantation: reliable therapy without severe side effects.
Greger B; Reis HJ; Mellert J; Schareck WD; Müller GH; Hopt UT; Bockhorn H
Transplant Proc; 1988 Oct; 20(5 Suppl 6):9-11. PubMed ID: 3051599
[No Abstract] [Full Text] [Related]
13. Clinical significance of albuminuria in renal transplantation.
Yanagisawa T; Kuzuhara K; Nishimori S; Kurooka Y; Yamada A; Harihara Y; Yokota K; Ogura Y; Otsubo O; Inou T
Transplant Proc; 1994 Aug; 26(4):2174-5. PubMed ID: 7915061
[No Abstract] [Full Text] [Related]
14. The role of antilymphocyte globulin in cadaver renal transplantation.
Novick AC
Transplant Proc; 1986 Jun; 18(3 Suppl 2):22-7. PubMed ID: 3521000
[No Abstract] [Full Text] [Related]
15. Antithymocyte globulin as the primary treatment for renal allograft rejection.
Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
[No Abstract] [Full Text] [Related]
16. Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection.
Kokot F; Wiecek A; Grzeszczak W; Lao M; Kuśmierski S; Cierpka L; Gradowska L; Jagiełło R
Transplant Proc; 1996 Dec; 28(6):3477-9. PubMed ID: 8962352
[No Abstract] [Full Text] [Related]
17. Uses of antilymphocyte globulin in renal transplantation.
Novick AC
Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
[No Abstract] [Full Text] [Related]
18. Monoclonal antibodies for kidney allograft rejection.
Med Lett Drugs Ther; 1986 Oct; 28(724):97-8. PubMed ID: 3531791
[No Abstract] [Full Text] [Related]
19. Pathology of canine renal allografts prolonged by sheep antilymphocyte plasma.
Fox M; Diethelm AG; Glassock RJ; Orr WM; Dubernard JM; Stuart FP; Dammin GJ; Murray JE
Invest Urol; 1971 Mar; 8(5):563-74. PubMed ID: 4104119
[No Abstract] [Full Text] [Related]
20. Monitoring the response to anti-rejection therapy with serum neopterin.
Smillie AE; Rigby RJ; Petrie JJ
Transplant Proc; 1989 Feb; 21(1 Pt 2):1869-70. PubMed ID: 2652608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
